Huang Yiming, Rezzoug Francine, Chilton Paula M, Grimes H Leighton, Cramer Daniel E, Ildstad Suzanne T
Institute for Cellular Therapeutics and the Department of Surgery, University of Louisville, Louisville, KY, USA.
Blood. 2004 Aug 1;104(3):873-80. doi: 10.1182/blood-2003-11-3910. Epub 2004 Mar 30.
The events that regulate engraftment and long-term repopulating ability of hematopoietic stem cells (HSCs) after transplantation are not well defined. We report for the first time that major histocompatibility complex (MHC) class I K plays a critical role in HSC engraftment via interaction with recipient natural killer (NK) cells. Durable engraftment of purified HSCs requires MHC class I K matching between HSC donor and recipient. In the absence of MHC class I K matching, HSCs exhibit impaired long-term engraftment (P =.01). Dependence on MHC class I K matching is eliminated in B6 beige mice that lack NK cell function, as well as in wild-type mice depleted of NK cells, implicating a possible regulatory role of NK cells for HSC engraftment. The coadministration of CD8+/T-cell receptor-negative (TCR-) graft facilitating cells (FCs) matched at MHC class I K to the HSC donor overcomes the requirement for MHC class I K matching between HSCs and recipient. These data demonstrate that FCs inhibit NK cell effects on the HSCs. Notably, FCs do not suppress the cytotoxic activity of activated NK cells. Enhanced green fluorescent protein-positive (EGFP+) FCs persist for one month following allogeneic transplantation, making cold target inhibition an unlikely mechanism. Therefore, MHC class I may play a critical role in the initiating events that dictate HSC engraftment and/or NK-mediated rejection following allogeneic transplantation.
移植后调节造血干细胞(HSCs)植入及长期重建能力的事件尚未明确界定。我们首次报道,主要组织相容性复合体(MHC)I类K通过与受体自然杀伤(NK)细胞相互作用,在HSC植入中起关键作用。纯化HSCs的持久植入需要HSC供体与受体之间的MHC I类K匹配。在缺乏MHC I类K匹配的情况下,HSCs表现出长期植入受损(P = 0.01)。在缺乏NK细胞功能的B6米色小鼠以及NK细胞耗竭的野生型小鼠中,对MHC I类K匹配的依赖性消除,这表明NK细胞对HSC植入可能具有调节作用。与HSC供体在MHC I类K上匹配的CD8 + /T细胞受体阴性(TCR -)移植促进细胞(FCs)的共同给药克服了HSCs与受体之间对MHC I类K匹配的需求。这些数据表明FCs抑制NK细胞对HSCs的作用。值得注意的是,FCs不会抑制活化NK细胞的细胞毒性活性。同种异体移植后,增强型绿色荧光蛋白阳性(EGFP +)FCs持续存在一个月,这使得冷靶抑制成为不太可能的机制。因此,MHC I类可能在决定同种异体移植后HSC植入和/或NK介导的排斥反应的起始事件中起关键作用。